The development of electrochemical recordings with small carbon-fiber electrodes has significantly advanced the understanding of the regulation of catecholamine transmission in various brain areas. Recordings in vivo or in slice preparations monitor diffusion of catecholamine following stimulated synaptic release into the surrounding tissue. This synaptic 'overflow' is defined by the amount of release, by the activity of reuptake, and by the diffusion parameters in brain tissue.
Dopaminergic transmission is characterized by transmitter 'spill-over', i.e. dopamine (DA) released by a presynaptic terminal can diffuse beyond the synaptic cleft to reach multiple postsynaptic targets (for review see Vizi 1982; Zoli et al. 1999; Gonon et al. 2000; Nicholson 2000; Rice 2000) . Accordingly, ultrastructural immunohistochemical studies have demonstrated that both DA receptors and uptake transporters are located extrasynaptically (Sesack et al. 1994; Yung et al. 1995; Nirenberg et al. 1997) . Another argument supporting 'spill-over' DA neurotransmission is that carbon-fiber electrodes (Kissinger et al. 1973; Gonon et al. 1980; Ewing et al. 1983; Millar et al. 1985; Marsden et al. 1988; Kawagoe et al. 1993; Michael and Wightman 1999) detect synaptically released DA at micromolar concentration, although the diffusion distance to the electrode comprises several microns.
An important aspect of this type of 'social' synapse is the impact of presynaptic regulation on transmitter release and reuptake. If release is enhanced and/or uptake reduced, the number of postsynaptic binding targets increases. In contrast, there has been a long debate about the physiological impact of presynaptic plasticity in fast excitatory or inhibitory synapses, traditionally thought of as point-to-point (or 'private') synapses enwrapped by glial processes that prevent transmitter diffusion out of the synaptic cleft. In recent studies, the concept of physiologically relevant transmitter 'spill-over' has been extended to GABAergic and glutamatergic synapses (Kullmann and Asztely 1998; Jahr 2003) , although its role and the conditions under which it may occur remain controversial.
In this review, we discuss the role of presynaptic DA transporters, autoreceptors, and heteroreceptors in the regulation of DA neurotransmission and mechanisms by which drugs of abuse and anti-psychotic drugs interfere with this regulation. We focus mostly on DAergic axon terminals, but also discuss some issues concerning somatodendritic DA release.
The DA transporter
The DA transporter (DAT) is a member of the family of biogenic amine transporters with 12 putative transmembrane domains (for recent reviews see Blakely and Bauman 2000; Torres et al. 2003) . In brain regions densely innervated by DAergic terminals (e.g. dorsal striatum, nucleus accumbens, olfactory tubercle), DA reuptake is the most important mechanism of DA inactivation (Jones et al. 1998b; BenoitMarand et al. 2000) . The DAT is a major target of psychostimulant drugs, particularly cocaine and amphetamine, which induce dramatic increases in extracellular DA concentrations. The DAT is localized on somata, dendrites, axons, and axon terminals of dopaminergic midbrain neurons (Nirenberg et al. 1996) . Ultrastructurally, DAT immunolabel is mostly present on extrasynaptic plasma membranes (Nirenberg et al. 1997) , supporting the idea of extrasynaptic transmission. Quantitative descriptions of the diffusion of DA in the brain's extracellular microenvironment and its restriction by uptake have been obtained by injecting defined amounts of DA solution into brain slice preparations and recording DA signals at a distance from the injection site (Rice et al. 1985; Nicholson 1995) . A comparison of somatodendritic regions [substantia nigra (SN) and ventral tegmental area (VTA)] and axon terminal regions (striatum) revealed that the amplitude and time course of DA signals are predominantly determined by uptake in the striatum and by diffusion in the SN and VTA (Cragg et al. 2001) .
DA uptake DA uptake follows Michaelis-Menten kinetics where the apparent affinity of uptake, K m , is a reciprocal measure of the affinity of a substrate for the uptake site, and V max is the maximal uptake velocity. V max is dependent on the number of uptake sites and is decreased by noncompetitive uptake inhibitors. K m is independent of the number of uptake sites and is increased by competitive uptake inhibitors (Horn 1979) . Tissue-specific parameters of DA uptake were initially derived from measurements of [ 3 H]DA uptake in synaptosome preparations (for review see Horn 1990) , and later from electrochemical measurements with rotating disk electrode voltammetry in striatal tissue suspensions (McElvain and Schenk 1992; Earles and Schenk 1998) . Recent studies have estimated uptake parameters in brain slices by either recording DA diffusion from injection sites (Nicholson 1995; Sabeti et al. 2002) , or by recording evoked endogenous DA overflow (Wightman and Zimmerman 1990; Jones et al. 1995b; Schmitz et al. 2001; Schonfuss et al. 2001; Wu et al. 2001b) .
Estimates for the K m of DA uptake range from 0.2 to 2 lM. A K m of 0.2 lM was determined for striatal synaptosome preparations (Near et al. 1988; Ross 1991) . Rotating disk voltammetry provided values between 0.6 and 1.2 lM for striatal tissue suspensions (McElvain and Schenk 1992; Earles and Schenk 1998) , and 2 lM for cell lines expressing the DAT (Wu and Gu 1999) . The studies using simulation models of stimulated DA overflow in the striatum derived K m values of 0.16 lM (Wu et al. 2001a) , 0.22 lM (Schonfuss et al. 2001) , and 0.8 lM (Schmitz et al. 2001) , respectively. V max expressed as lM/s can be calculated from the initial slope of the falling phase of DA overflow recordings, provided the evoked DA release is sufficiently high (Kawagoe et al. 1992) . The peak of DA overflow in response to a single electrical stimulation in the dorsal striatum in vitro is 1 lM DA, as measured by cyclic voltammetry. This translates into an initial (immediately after release) DA concentration of 2-4 lM according to simulation models that account for the filtering of the signal caused by diffusion to the electrode. V max values between 4 and 6 lM/s have been determined for dorsal striatum from simulation of DA overflow recorded in response to single stimulation in vitro, and to multiple stimulation in vivo Wightman and Zimmerman 1990; Jones et al. 1995b; Cragg et al. 2000; Schmitz et al. 2001; Schonfuss et al. 2001; Wu et al. 2001b) . There are regional variations in V max within the dorsal striatum that may reflect different functional domains (Cragg et al. 2002) . DA uptake in the ventral striatum (Nucleus accumbens, N. acc.) was reported to be less efficient than in the dorsal striatum (Stamford et al. 1988b; Cass et al. 1992; Suaud-Chagny et al. 1995) , with estimates for V max of 2 lM/s and 0.6 lM/s in the N. acc. core and shell, respectively (Jones et al. 1996b) . DA uptake in the prefrontal cortex and amygdala appears to be very low Sesack et al. 1998) with V max values around 0.05 lM/s and 0.5 lM/s, respectively (Jones et al. 1995b; Mundorf et al. 2001) . In areas with low DAT activity, the norepinephrine transporter (NET) and the serotonin transporter (SERT) may participate in DA uptake (Yamamoto and Novotney 1998; Miner et al. 2000; Cragg et al. 2001; Moron et al. 2002) . In addition, enzymatic breakdown by catechol-O-methyltransferase plays a role in DA clearance in these brain regions (Wayment et al. 2001; Matsumoto et al. 2003) .
The role of DA uptake in DA transmission DAergic neurons exhibit two kinds of discharge activity. In the rodent, these correspond to single spikes at a mean frequency below 5 Hz and bursts of two to six action potentials with an intraburst frequency of 15-30 Hz (Grace and Bunney 1984a,b) . Individual DAergic neurons can switch from one pattern to another and in unrestrained rats the bursting pattern is favored in response to sensory stimuli (Freeman and Bunney 1987) . In monkeys, midbrain neurons respond to an appetitive or conditioned stimulus by a single burst (Schultz et al. 1997) . Grace and Bunney (1984a,b) hypothesized that 'bursting may be as important as firing frequency in affecting DA release' and this hypothesis was supported by early studies (Gonon and Buda 1985; Gonon 1988 ). More recently, it has been shown that the main mechanism subserving the high extracellular DA level evoked by stimulations mimicking the bursting activity is not facilitation of DA release per se, but accumulation of the released DA as a result of saturated DA uptake (Chergui et al. 1994) . During tonic activity, the DA released by single spikes is cleared before the next spike. In contrast, during a burst, released DA accumulates in the extracellular space. This accumulation is more obvious in the nucleus accumbens and olfactory tuberculum than in the dorsal striatum because DA reuptake is more potent in the dorsal striatum than in the other regions (Chergui et al. 1994; Suaud-Chagny et al. 1995) . Therefore, due to reuptake, tonic activity and bursting activity result in different extracellular DA levels.
Accordingly, in mice lacking the DAT, the released DA accumulates during tonic activity with no further enhancement during burst activity . Interestingly, these mice are hyperactive, due to their high basal extracellular level, but show an impairment in spatial learning and 'difficulties in suppressing inappropriate responses' (Gainetdinov et al. 1999 ). These cognitive deficits might occur because these mice are not able to translate bursting activity involved in learning into phasic changes in extracellular DA . The extracellular accumulation of DA elicited by bursts is required to significantly activate D2 autoreceptors (Benoit-Marand et al. 2001) and to stimulate postsynaptic D1 receptors (Chergui et al. 1996; Chergui et al. 1997; Gonon 1997) . All these data point out the importance of DA reuptake in the differential expression of bursts and single spike discharge activity of DAergic neurons.
Finally, DA uptake has been suggested to play a role in refilling intracellular DA stores, particularly during prolonged DA release . In accordance with this hypothesis, DA release is more dependent on DA synthesis, and the rate of DA synthesis is doubled, in mice lacking the DAT (Jones et al. 1998b; Benoit-Marand et al. 2000) .
DAT functions beyond uptake
The DAT, in addition to uptake, also elicits ion channel-like currents in response to substrates such as DA and amphetamine (Khoshbouei et al. 2003) . In cultured rat DA neurons, transport of DA, at concentrations lower than necessary for D2 receptor activation, stimulated an anion conductance causing an excitatory response (Ingram et al. 2002) . The authors suggested that under conditions of low extracellular DA, depolarization due to DAT activity facilitates DA release. With higher extracellular DA concentrations this effect would be suppressed by the activation of inhibitory autoreceptors.
Another recent study suggested that the DAT may mediate DA release directly via the reversal of transport, a mechanism previously only associated with the action of amphetamine (see section on Amphetamine). In a slice preparation, DA release was elicited from dendrites and somata in the SN reticulata by stimulation of the glutamatergic projection from the subthalamic nucleus and was abolished by DAT inhibitors. The authors suggested that stimulation-dependent reverse transport of DA may occur if dendrites are depolarized beyond the reversal potential for DA transport. This nonvesicular DA release would cause feedback inhibition of the DA neuron via autoreceptor activation, thereby shaping the firing response (Falkenburger et al. 2001) .
Cocaine
The first indication that cocaine may act as an amine uptake inhibitor came from Burn and Rand, who suggested 'the action of cocaine may be to arrest the release of the noradrenaline-like substance from the store' (Burn and Rand 1958) . Later work demonstrated neuronal binding sites for [ 3 H]cocaine (Reith et al. 1980) , and that DAT binding sites were related to self-administration of the drug (Ritz et al. 1987) . The effects of cocaine on motor activity and reward systems have been well documented. While blockade of DA reuptake by cocaine appears a sufficient explanation for its locomotion-inducing effect, the reinforcing effects of cocaine may involve several amine transporters (Uhl et al. 2002) . Thus, cocaine maintains reinforcing properties in mice lacking the DAT (Giros et al. 1996; Rocha et al. 1998; Sora et al. 1998) , and elevates DA levels in the N. acc. of these animals (Carboni et al. 2001) . This effect of cocaine in DAT knockout mice is not mediated by the blockade of the NET and the SERT in the N. acc., and is most likely located outside of this structure . In mice lacking both the DAT and the SERT, cocaine place preference is eliminated (Sora et al. 2001) .
The uptake inhibition by cocaine has been variously reported to follow competitive (Calligaro and Eldefrawi 1987; Krueger 1990; Jones et al. 1995a; Chen and Justice 1998; Wu et al. 2001a) , noncompetitive, or uncompetitive kinetics (McElvain and Schenk 1992; Wheeler et al. 1994; Povlock and Schenk 1997) . Studies supporting competitive inhibition report a decrease in the apparent affinity, with a K m ranging from 2.5 lM (Jones et al. 1995b; Jones et al. 1995a) to 11 lM (Wu et al. 2001a) for 10 lM cocaine. In any case, cocaine is not a substrate for the DAT and is not internally transported .
The efficacy of cocaine depends on the ongoing release of DA. The increased extracellular DA levels resulting from cocaine uptake blockade, however, might eventually activate DA D2 autoreceptors and shut down subsequent DA release (see section on The D2 autoreceptor). Accordingly, an in vitro study on axon terminal DA release reported that there was an acute autoreceptor response in the presence of uptake blockade resulting in a reduction of DA release in the N. acc., although not in the dorsal striatum (Wieczorek and Kruk 1994a) . Consistent with this idea, extracellular DA levels in response to cocaine assessed by in vivo microdialysis were higher in mice lacking D2 receptors than in wildtype mice (Rouge-Pont et al. 2002) . Nevertheless, even in the presence of D2 autoreceptors, the net result of DA uptake inhibition by cocaine is an elevation of extracellular DA levels.
Many studies have addressed the question whether chronic cocaine treatment and withdrawal alters the activity/expression of D2 autoreceptors and the DAT itself in different brain regions (for review (Kuhar and Pilotte 1996; White and Kalivas 1998; Zahniser and Doolen 2001) . While somatodendritic D2 autoreceptors in the VTA become subsensitive during cocaine treatment (Henry et al. 1989; Ackerman and White 1990; Lee et al. 1997; Henry et al. 1998) , results from studies on axon terminal autoreceptors are contradictory. One important factor appears to be the regimen of cocaine administration. Intermittent cocaine treatment may lead to subsensitivity, and continuous cocaine treatment to supersensitivity of axon terminal D2 autoreceptors (Yi and Johnson 1990; Jones et al. 1996a; Howard et al. 1997; King et al. 1999; Davidson et al. 2000) . In the case of a developmental absence of DAT-mediated uptake, as in DAT knockout mice, D2 autoreceptor expression is reduced to less than half of wild-type level, and autoreceptor activity is virtually absent (Jones et al. 1999b) .
Recent studies indicate that acute cocaine treatment blocks the turnover and mobilization of the DAT so that more DAT protein is expressed in the plasmalemmal membrane (Daws et al. 2002; Little et al. 2002) . With chronic cocaine treatment, most evidence points to a decrease in DAT expression following a sufficient withdrawal period (Kuhar and Pilotte 1996) , although both decreased and increased mRNA/protein levels have been reported (for a recent review of the literature see Kimmel et al. 2003) .
Amphetamine Amphetamine (AMPH), in contrast to cocaine, is a substrate for both the DAT and the NET and is a competitive inhibitor of DA uptake (Heikkila et al. 1975; Wieczorek and Kruk 1994b; Sonders et al. 1997; Jones et al. 1999a; Khoshbouei et al. 2003) . Based on results from electrochemical recordings, it was estimated that AMPH (10 lM) decreases the apparent affinity of the DAT from a K m value of 0.8 to 30 lM (Schmitz et al. 2001) . In addition, AMPH and its derivatives promote DA efflux by reverse transport through monoamine uptake transporters (Heikkila et al. 1975; Fischer and Cho 1979; Raiteri et al. 1979; Parker and Cubeddu 1986; Sulzer et al. 1993; Sulzer et al. 1995; Jones et al. 1998a; Schmitz et al. 2001) . The DA efflux caused by AMPH activates D2 autoreceptors and thereby inhibits stimulation-dependent DA release (Wieczorek and Kruk 1994b; Iravani and Kruk 1995; Schmitz et al. 2001) . Vesicular DA release is further decreased by AMPH as it promotes the redistribution of DA from synaptic vesicles to the cytosol (Sulzer et al. 1995; Mosharov et al. 2003) by collapsing the vesicular pH gradient (Sulzer and Rayport 1990) . Thus, the overall effect of AMPH is a reduction of activity-dependent, vesicular DA release, inhibition of DA uptake, and an induction of continuous DA efflux by reverse transport. The effects of cocaine and AMPH on dopaminergic transmission differ significantly, for cocaine enhances and prolongs activity-dependent, exocytotic DA signals, whereas AMPH causes continuous DA efflux independently from firing activity while dampening but prolonging synaptically released DA.
Acute AMPH treatment has been shown to cause DAT internalization in in vitro and in vivo studies (Saunders et al. 2000; Gulley et al. 2002) , although not in all systems (Daniels and Amara 1999) . In fact, cocaine and other DA uptake blockers (mazindol and nomifensine) inhibited AMPH-induced internalization of the DAT (Saunders et al. 2000) suggesting that inhibitors stabilize DAT expression in the membrane, whereas DAT substrates such as AMPH and DA itself induce internalization. This process most likely involves PKC-dependent pathways (Sandoval et al. 2001; Gulley et al. 2002) , as numerous studies have shown that PKC activation results in DAT internalization (Copeland et al. 1996; Huff et al. 1997; Vaughan et al. 1997; Zhang et al. 1997; Zhu et al. 1997; Pristupa et al. 1998; Daniels and Amara 1999; Melikian and Buckley 1999) . A direct phosphorylation of the DAT by PKC does not appear to be required in the pathway (Granas et al. 2003) . The effects of chronic treatment with AMPH on DAT expression are not as well characterized, and the results thus far are not conclusive. Some studies reported no changes in DAT mRNA (Kula and Baldessarini 1991; Persico et al. 1993; Mintz et al. 1994) , whereas other studies reported an up-regulation of DAT mRNA in response to several days of AMPH injections followed by several days of withdrawal (Lu and Wolf 1997; Shilling et al. 1997 ).
The DA autoreceptor
The term 'autoreceptor' was coined in 1975 by Arvid Carlsson for DA autoreceptors (Carlsson 1975; Starke 2001) . Although doubts have been expressed about the physiological significance of autoreceptor regulation in certain transmitter systems (Kalsner 2001) , it is clear that DA autoreceptors provide the DA midbrain neuron with a complex feedback system at the soma and the axon terminal.
DA autoreceptors belong to the D2-family (D2, D3, D4) of DA receptors that are coupled to inhibitory G proteins and modulate ion channel activity and/or depress adenylyl cyclase. D2 receptors are expressed by somata and dendrites of SN and VTA neurons, as well as by their axon terminals in the striatum and N. acc. (Sesack et al. 1994) . Studies on D2 receptor knockout mice reported no detectable autoreceptor response to D2-class receptor agonists with respect to regulation of firing rates, DA release and DA synthesis. These results implicated the D2 receptor as the only functional autoreceptor in the D2-family (Mercuri et al. 1997; L'hirondel et al. 1998; Benoit-Marand et al. 2001; Schmitz et al. 2002) . There exists, however, evidence for a contribution of D3 receptors to autoreceptor function. In the SN and VTA, some DA neurons appear to express D3 receptor immunoreactivity, whereas the axons and axon terminals in N. acc. and striatum lack D3 receptor label (Diaz et al. 2000) . Studies on transfected cells demonstrated that D3 receptors can modulate the same ion channels (G proteinactivated inwardly rectifying potassium channels, GIRKs) as D2 receptors (Kuzhikandathil and Oxford 1998; Oxford 1999, 2000) , and have the potential to affect DA release and synthesis (Tang et al. 1994; O'Hara et al. 1996) . This was not confirmed, however, by a recent study on acutely dissociated midbrain neurons from D2 receptor knockout mice that did not find any evidence for D3 receptor-mediated activation of GIRK currents (Davila et al. 2003) . Several pharmacological in vivo studies support a role for D3 receptors as autoreceptors (Rivet et al. 1994; Aretha et al. 1995; Kreiss et al. 1995; Lejeune and Millan 1995; Gainetdinov et al. 1996) , although this evidence is weakened by the poor selectivity of available DA receptor agonists and antagonists. An earlier study on a mouse line lacking D3 receptors reported no alterations in autoreceptor function, but a role of D3 receptors in the circuit regulating DA levels (Koeltzow et al. 1998) . In contrast, a recent study on another D3 receptor knockout mouse line provided evidence that D3 receptors may participate directly in regulating DA secretion (Joseph et al. 2002) . A study on rats treated with D3 receptor antisense oligodeoxynucleotides suggested a role for D3 receptors in regulating firing rates (Tepper et al. 1997) .
There is little evidence supporting a role of D4 receptors as autoreceptors beyond a recent immunohistochemistry study that demonstrated presynaptic D4 receptor localization in a subset of mesoaccumbal terminals in the N. acc. shell (Svingos et al. 2000) . D4 antagonists have been reported to affect DA levels in the N. acc. in a microdialysis study (Broderick and Piercey 1998) , and in D4 receptor knockout mice, DA synthesis and turnover are increased, a possible indication for altered autoreceptor function. Given the weak evidence for D4 autoreceptors, the authors of the latter study argued that the observed change in DA metabolism in D4 knockout mice might rather be due to indirect circuit effects involving glutamatergic afferents (Rubinstein et al. 1997) . In accordance with a lack of an autoreceptor role for D4 receptors, studies on transfected dopaminergic cell lines reported that D4 receptor expression did not regulate DA release and synthesis (Tang et al. 1994; O'Hara et al. 1996) . In summary, it appears that DA autoreceptor function is predominantly carried out by D2 receptors, with a putative minor contribution from D3 receptors. In recent studies, it has been suggested that the two isoforms of the D2 receptor generated by alternative splicing, D2S and D2L, may serve different pre-and postsynaptic functions (Khan et al. 1998) . It was reported that the D2 receptor agonist quinpirole was still able to inhibit DA release in D2L knockout mice (Usiello et al. 2000; Wang et al. 2000) . Moreover D2 receptor agonist effects on membrane potential were preserved in D2L knockout mice (Centonze et al. 2002) . These results indicate that D2L receptors may act mostly as postsynaptic receptors and D2S receptors as presynaptic autoreceptors. While this hypothesis will need further experimental support, it could potentially lead to the development of specific antagonists and agonists for pre versus postsynaptic D2 receptors that may be useful to improve pharmacological treatment of neuropsychiatric and movement disorders.
Firing rate
It is well established that D2 autoreceptors modulate the membrane potential of DAergic mesencephalic neurons. D2 receptor activation elicits a hyperpolarization and decreases the firing rate (Bunney et al. 1973; Silva and Bunney 1988; Rayport et al. 1992; Mercuri et al. 1997) due to activation of a GIRK conductance (Lacey et al. 1987; Kim et al. 1995; Cathala and Paupardin-Tritsch 1999) . The firing pattern that DA midbrain neurons exhibit in vivo, either single spike firing or burst firing (Grace and Bunney 1984a,b) , depends mainly on the excitatory and inhibitory afferent inputs (Kitai et al. 1999) , which are in turn modulated by DA release (Paladini et al. 2003) . Treatment with D2 receptor antagonists in vivo increases the proportion of spontaneously firing DA cells, increases the firing rate, and shifts the firing pattern from single spike discharge to burst firing. Repeated administration of D2 receptor antagonists can eventually lead to a depolarization block of DA neurons in anaesthetized animals. The degree to which D2 autoreceptor blockade contributes to these responses, however, is not clear (Bunney and Grace 1978; Grace et al. 1997) , and whether depolarization activation may be related to the type of anesthesia remains controversial (Melis et al. 1998) .
DA release D2 autoreceptor activation inhibits axon terminal (Seeman and Lee 1975; Starke et al. 1978; Cubeddu and Hoffmann 1982; Gonon and Buda 1985; Dwoskin and Zahniser 1986; Mayer et al. 1988; Stamford et al. 1988a; May and Wightman 1989; Palij et al. 1990; Suaud-Chagny et al. 1991; Kennedy et al. 1992; Cragg and Greenfield 1997) and somatodendritic DA release . Patch clamp studies on DA midbrain neurons in vitro have revealed a D2 receptor regulation of voltage-gated calcium currents (Cardozo and Bean 1995) , and axon terminal DA release has been shown to be dependent on N and P/Q type calcium channels (Phillips and Stamford 2000) . Given the dependence of transmitter release on calcium influx, modulation of calcium channels appears to be a reasonable mechanism for D2 receptor-mediated DA release inhibition. This has not been proven directly, however, and a recent study on autapses (i.e. synapses that a cells makes with itself) of midbrain neurons in culture found no evidence for a D2 autoreceptor regulation of calcium influx (Congar et al. 2002) . Instead, the authors presented evidence that D2 receptor-mediated release inhibition may involve 4-aminopyridine-sensitive K + channels that act downstream from calcium influx. A drawback of this study is that the autapses of cultured DA neurons are glutamatergic , and it is not known whether this finding can be extrapolated to DA release. Finally, while somatodendritic DA release is also calcium-dependent (Kalivas and Duffy 1991; Rice et al. 1997) , it exhibits, in contrast to the typically nonlinear dependence of release on extracellular calcium, a linear dependence in very low extracellular calcium concentrations, saturating around 1 lM (Chen and Rice 2001) .
While there is no disagreement that D2 receptors inhibit DA release, estimates of the time of onset and the duration of release autoinhibition have been considerably variable. The estimated duration of axon terminal release autoinhibition in different preparations ranges from tens of milliseconds up to several seconds (Mayer et al. 1988; Limberger et al. 1991; Kennedy et al. 1992; Dugast et al. 1997; Benoit-Marand et al. 2001; Phillips et al. 2002; Schmitz et al. 2002) . Possible reasons for this divergence might be found in variations between in vitro and in vivo conditions or in species differences. A recent pharmacological in vitro study (Phillips et al. 2002) , and two studies on D2 receptor knockout mice (Benoit-Marand et al. 2001; Schmitz et al. 2002) derived congruent estimates for the time course of the D2 effect on axon terminal DA release. In these studies, the onset of the D2 effect was between 50 ms and 100 ms, the maximum effect between 300 ms and 550 ms. The duration was about 800 ms in the in vivo study and less than 5 s in the two in vitro studies. The slightly longer time course determined in the in vitro studies is likely due to the larger amount of DA released per stimulation in slice preparations.
This timing of D2-mediated release autoinhibition might be suited to depress or enhance the DA signal in response to different firing patterns of midbrain neurons. The basal firing rate of midbrain neurons in the rat is 4 Hz, interrupted by burst firing of 2-6 pulses at 15 Hz (Grace and Bunney 1984a,b) . Recordings of SN neurons in monkeys have shown that burst firing occurs in response to reward and after a learning period in response to the conditioning stimulus (Schultz et al. 1997) . According to the time course of release autoinhibition, DA release is tonically depressed during basal firing, whereas less inhibition occurs during burst firing (within the first three spikes). In addition, burst firing transiently attenuates subsequent DA release elicited by tonic discharge activity. In this way, autoinhibition of DA release may serve to enhance the signal-to-noise ratio of the DA signal in response to 'meaningful' burst firing versus baseline firing.
DA synthesis
With the exception of mesoprefrontal axon terminal autoreceptors (Chiodo et al. 1984; Galloway et al. 1986) , there is accumulating evidence that D2 receptors modulate DA synthesis by decreasing tyrosine hydroxylase (TH) activity (Kehr et al. 1972; Roth et al. 1975; Kapatos and Zigmond 1979; Haubrich and Pflueger 1982; el Mestikawy and Hamon 1986; Strait and Kuczenski 1986; Wolf et al. 1986; Wolf and Roth 1990; O'Hara et al. 1996) . The underlying pathway involves most likely inhibition of adenylyl cyclase and a cAMP-dependent change in phosphorylation of TH (Onali and Olianas 1989; Salah et al. 1989; Lindgren et al. 2001) . A direct link between D2 receptor-mediated inactivation of DA synthesis and reduced DA release has been shown for PC12 cells, but not yet for neurons. Incubation of PC12 cell cultures with D2 receptor agonists resulted in decreased DA synthesis and a reduced frequency and size (molecules per vesicle) of quantal release (Pothos et al. 1998b) . Thus, DA release can be regulated by D2 autoreceptors on two different time scales, a fast one lasting no longer than a few seconds likely involving ion channel modulation, and a slow one that may last for minutes to hours and involves regulation of DA synthesis.
Interaction with the vesicular transporter
Few studies have investigated the possibility that the expression of neuronal vesicular monoamine transporter (VMAT2) is regulated, either in general or by D2 autorecceptors specifically. An initial autoradiography study reported no change in VMAT2 label after repeated in vivo treatment with dopaminergic drugs (Vander Borght et al. 1995) . In contrast, two recent publications (Brown et al. 2001; Brown et al. 2002) suggested a regulation of the expression of VMAT2 by D2 autoreceptors. Cocaine treatment increased the uptake of DA into synaptic vesicles, an effect blocked by D2 receptor antagonists. Conversely, D2 receptor agonists increased vesicular DA uptake (Brown et al. 2001) . In a subsequent study, a decrease in VMAT2 activity was induced by a single treatment with the DA releasing drug methamphetamine, which was also blocked by D2 receptor antagonists (Brown et al. 2002) . A recent, ultrastructural immunogold label study (Pickel et al. 2002) also suggested that D2 receptors could in principle regulate dendritic VMAT2 expression, based on the close association between dendritic D2 receptors and VMAT2 containing vesicles. This pathway would present a third mechanism, in addition to regulation of ion channel conductance and DA synthesis, by which D2 autoreceptors regulate DA release.
Interaction with the plasmalemmal DA transporter Several studies have provided evidence that D2 autoreceptors modulate DA reuptake (Meiergerd et al. 1993; Parsons et al. 1993; Cass and Gerhardt 1994; Wieczorek and Kruk 1994a; Batchelor and Schenk 1998; Dickinson et al. 1999; Kimmel et al. 2001; Mayfield and Zahniser 2001; Schmitz et al. 2002; Wu et al. 2002) . Immediate regulation of DA uptake by D2 receptors may occur through the voltage dependence of uptake Hoffman et al. 1999) , although this mechanism was not supported by studies utilizing midbrain cell cultures (Prasad and Amara 2001) . D2 receptor-mediated changes in DAT activity may involve phosphorylation, trafficking, and/or expression of the DAT. The second messengers that may mediate these actions are not well characterized. PKC activation has been shown to reduce DAT activity through enhanced internalization and reduced delivery to the membrane (Copeland et al. 1996; Huff et al. 1997; Vaughan et al. 1997; Zhang et al. 1997; Zhu et al. 1997; Pristupa et al. 1998; Daniels and Amara 1999; Melikian and Buckley 1999) . Although it is possible that D2 receptor activity is linked to PKC-mediated pathways (Iannazzo et al. 1997; Huff et al. 1998) , there is thus far no direct evidence that D2 receptors affect the DAT via PKC. Several studies demonstrated that D2 receptor antagonists inhibit DAT activity, suggesting that D2 autoreceptor activation promotes DAT activity (Meiergerd et al. 1993; Cass and Gerhardt 1994; Rothblat and Schneider 1997; Benoit-Marand et al. 2001; Wu et al. 2002) . The effect of D2 receptor agonists on DAT activity, however, is less clear. In striatal suspensions, quinpirole stimulated DA uptake by a PKAdependent pathway possibly via transient enhancement of DAT insertion into the membrane (Batchelor and Schenk 1998) . In striatal slice preparations, however, quinpirole does not appear to induce any detectable effect on DA uptake under normal conditions (Joseph et al. 2002) .
The effect of chronic D2 receptor stimulation on DAT expression is also not clear. Chronic treatment with D2 receptor agonists was reported to result in increased DAT expression in the N. acc., and decreased DAT expression in the caudate putamen (Kimmel et al. 2001) . Altered DAT levels have been reported in schizophrenic patients, although it is unknown if this represents a manifestation of the disease or a consequence of anti-psychotic drug treatment (Dean and Hussain 2001; Laakso et al. 2001) .
Studies on three different mouse lines lacking D2 receptors also addressed potential alterations of DAT activity, with different outcomes. In a mouse line with a deletion mutation for the D2 receptor (i.e. a truncated form of the receptor is still expressed), DAT activity was decreased based on the kinetics of DA reuptake of injected DA solution into the striatum (Dickinson et al. 1999) . In a D2 receptor knockout mouse line (Baik et al. 1995) , an in vivo study using amperometric recordings of evoked DA release reported no apparent change in uptake based on the half-life of DA overflow (Benoit-Marand et al. 2001) . In contrast, immunostaining with antibodies against the DAT revealed an increased density of DAT-containing fibers in the striatum of this mouse line (Parish et al. 2001) . In another knockout mouse line (Jung et al. 1999) , a study on evoked DA overflow in striatal slices found an increase in DA uptake activity, based on the half life of evoked DA overflow and effects of DAT blockers (Schmitz et al. 2002) .
To summarize, there is accumulating evidence that D2 receptors regulate DAT activity. The conditions under which autoreceptors activate or inhibit DA uptake, and the mechanisms that are involved in the regulation remain unclear and need to be delineated. An altered DAT expression in DA terminals in response to chronic autoreceptor activation may explain some of the characteristic responses seen with antipsychotic drug treatment, such as the alleviation of the hyperdopaminergic state in schizophrenic patients, and the delay in the full response to treatment.
Heteroreceptors on nigrostriatal axon terminals
Most of the efforts in characterizing receptor-mediated presynaptic modulation of evoked DA release in the striatum have examined the D2 autoreceptor, but additional neurotransmitter receptors are present on nigrostriatal terminals. Electron microscopic demonstration of heteroreceptor immunolabel in DA terminals is clearly invaluable for establishing their presence, but there are relatively few studies in this area. One technical difficulty is that double staining with a marker for nigrostriatal terminals, such as tyrosine hydroxylase, is required. There are also technical obstacles to measuring terminal heteroreceptor effects on synaptic DA release. Synaptosomal preparations are useful for ascertaining if there is a response to a given agonist, but provide poor kinetic resolution. Numerous microdialysis studies have provided evidence for heteroreceptor regulation of DA release, however, with this technique it is not always possible to exclude circuit effects. We limit the discussion here to data obtained by real-time electrochemical recordings of electrically evoked axon terminal DA release in vitro, although this approach also has to consider circuit effects (Avshalumov et al. 2003) .
A role for glutamate receptors on striatal DA terminals has been implicated in two studies that demonstrated attenuation of evoked DA release in response to the glutamate antagonist kynurenate and glutamate itself (Wu et al. 2000; Kulagina et al. 2001) . It is unclear why agonists and antagonists have similar effects, and the role and even presence of presynaptic ionotropic glutamate receptors in DA terminals remains to be demonstrated (Bernard and Bolam 1998; . A recent study suggested that the inhibitory effects of glutamate on striatal DA release are indeed indirect and are mediated by the AMPA receptor-dependent production of the diffusible messenger H 2 O 2 (Avshalumov et al. 2003) . In contrast to ionotropic glutamate receptors, the metabotropic receptor mGluR1 has been observed by ultrastructural immunolabel in striatal DA terminals (Yoland Smith, personal communication) , and a direct effect of metabotropic glutamate receptor activation in regulating evoked DA release is possible (Zhang and Sulzer, 2003) .
The nicotinic acetylcholine receptor is presynaptic in a wide variety of neuronal synapses (McGehee et al. 1995) and there is immunohistochemical evidence for its presence on DA terminals (Wonnacott et al. 2000) . Electrochemical studies demonstrated an inhibition of evoked DA release by muscarinic and nicotinic agonists (Kudernatsch and Sutor 1994) . It may be that the acute effect of nicotine on DA release is excitatory, but the receptor is rapidly desensitized during the recordings (Zhou et al. 2001) .
GABA B receptor agonists inhibit evoked DA release measured electrochemically in the striatal slice with kinetic parameters similar to those of the D2 autoreceptor (Schmitz et al. 2002) . There is ultrastructural evidence consistent with expression of GABA B receptors on DA terminals (Charara et al. 2000) . Thus, there are at least two G-protein-coupled receptors for classical neurotransmitters on DA terminals that produce similar effects.
Ultrastructural studies show that delta and kappa opioid receptors are present on striatal DA terminals (Svingos et al. 1999; Svingos et al. 2001) . There are numerous additional ionotropic and G-protein-linked receptor candidates that may act as heteroreceptors on DA terminals, and elucidation of their effects is fundamental for understanding modulation of dopaminergic transmission.
A receptor complex for glial-derived neurotrophic factor (GDNF) appears to be present on nigrostriatal terminals (Araujo et al. 1997) . GDNF delivery to the striatum, the SN, or the ventricles promoted axonal sprouting and enhanced TH activity and DA release in vivo (Gash et al. 1996; Hebert et al. 1996; Rosenblad et al. 1998; Grondin et al. 2003) . In cultured midbrain neurons, GDNF increased the quantal size of DA release (see below (Pothos et al. 1998a) . It may be that there is a developmental window during which GDNF, and likely other growth factors, can exert effects on nigrostriatal terminals.
Retrograde messengers
In glutamatergic synapses, several retrograde messengers have been identified that are released postsynaptically and feed back on to the presynaptic site to affect transmitter release. In DA synapses, no clear evidence for retrograde signaling has yet been reported. Destruction of the target neurons in the striatum by kainate injections had no effect on the presynaptic characteristics of DA transmission (Gonon 1986) . Similarly, there was no effect on DA release and uptake in mice lacking endogenous inhibitors of protein phosphatase-1 (DARP-32, or inhibitor-I, or both), which participates in a major signaling pathway activated by postsynaptic DA receptors (Zachariou et al. 2002) . Likewise, preliminary in vivo experiments with mice lacking the exclusively postsynaptic D1 DA receptor show no obvious alterations in the presynaptic regulation of evoked DA overflow (Mallet and Gonon, unpublished observations).
Quantal size
The term 'quantal size' was originally defined as the magnitude of miniature excitatory postsynaptic potentials in response to the exocytosis of single vesicles. This term was appropriated for the number of neurotransmitter molecules released during synaptic vesicle fusion which can be determined directly for catecholamine containing vesicles by electrochemical recordings (Sulzer et al. 1995; Pothos et al. 1996) . Numerous interventions have now been reported to alter presynaptic quantal size, as discussed in a recent review . Only a few studies have been performed on neurons, and fewer still on cultured catecholamine containing neurons, although some preparations may be adapted for such experiments (Jaffe et al. 1998; Puopolo et al. 2001) . Synaptic vesicle fusion in cultured ventral midbrain DA neurons typically releases 3000 DA molecules per quantum during 100 ls. A variety of interventions that decrease quantal size in chromaffin cells and other neurosecretory cells probably do so in DA midbrain neurons as well. For instance, reserpine decreases quantal size in chromaffin and PC12 cells (Kozminski et al. 1998; Colliver et al. 2000) , and chronic activation of D2 autoreceptors decreases quantal size in the PC12 cell line (Pothos et al. 1998b) . The lack of data on interventions that decrease quantal size in midbrain DA neurons is mostly due to the very small quantal size, which is more than 2-3 orders of magnitude smaller than in chromaffin cells. Thus, most of the reported modulation of quantal size in midbrain neurons is on interventions that increase quantal size.
Short-term incubation (30 min) of neuronal cultures with L-DOPA, a precursor for DA, rapidly increased quantal size by 4-fold. Application of GDNF elevated quantal size to a similar extent, but the effect required several days to occur (Pothos et al. 1998a) . Alterations in quantal size by drugs that alter PKC activity have recently been observed (Roland Staal, manuscript in submission). Another example of regulation of quantal size is the overexpression of the vesicular monoamine transporter VMAT2 in cultured midbrain neurons. VMAT2 overexpression increased not only the size but also the frequency of quantal events, apparently by converting the neurochemical phenotype of synaptic vesicles that did not formerly release DA . Thus, it is possible for a single intervention to modulate both quantal size and the frequency of vesicle exocytosis. Aside from the evidence discussed in the section 'Interaction with the vesicular DA transporter', it is presently unclear whether and how expression of VMAT2 is regulated under physiological conditions.
Releasable vesicular pool
DA release elicited in striatal slice preparations exhibits a pronounced and long lasting paired pulse depression (PPD), i.e. the amount of DA release elicited by the second stimulus is reduced compared to the DA release elicited by the first stimulus. Full recovery takes about 60 s, and is fitted by a double exponential function with time constants of 5 s and 25 s (Kennedy et al. 1992; Abeliovich et al. 2000; Phillips et al. 2002) . The situation in vivo is quite different, however. The amplitude of DA overflow recorded in response to a single stimulation of the medial forebrain bundle is about 10 times smaller than the amplitude of DA overflow evoked by direct stimulation in the striatum in vitro. There appears to be no depression of DA release (apart from D2 receptormediated autoregulation) for stimulation frequencies from 4 to 100 Hz (Chergui et al. 1994; Dugast et al. 1997; Benoit-Marand et al. 2001) . A careful re-examination, however, revealed that at least a moderate PPD may also exist in vivo, i.e. for an interstimulus interval of 1 s there is a PPD of 35% (Benoit-Marand and Gonon, unpublished data). The reason for this difference in PPD of DA release in vitro and in vivo is not understood. One obvious difference between the in vivo and in vitro situation is the absence of spontaneous DA release in slice preparations, whereas in vivo there is a tonic activity of DAergic midbrain neurons and presumably tonic DA release from the terminals in the striatum. Stimulation of the slice with a regular pattern, however, does not emulate the release behavior found in vivo. Moreover, reducing the stimulation current in vitro, so that only half of the maximal DA release is elicited, does not accelerate the recovery rate but slows it even further (Schmitz, Benoit-Marand, Gonon, and Sulzer, unpublished data) .
Two manipulations have been shown to accelerate the recovery of striatal DA release from PPD in vitro. An incidental finding was that in a-synuclein knockout mice recovery from PPD is accelerated, with time constants of 5 and 16 s (Abeliovich et al. 2000) . a-synuclein is a presynaptic protein of unknown function, although it has been shown to affect the vesicular pool size (Murphy et al. 2000; Cabin et al. 2002) . Elevated extracellular calcium (10 mM versus 2.4 mM) also accelerated the recovery rate of DA release (time constants of 2.5 and 18 s), while also enhancing the amount of DA released by the first stimulation, as expected from the dependence of vesicular release on calcium (Abeliovich et al. 2000) .
More work is clearly required to understand the pronounced PPD of DA release in vitro and the behavior of these synapses in vivo. From the in vitro data, it appears as if releasable vesicular pools in DA synapses may be up-regulated quickly after activity stops, and/or release probability may increase. So far, such plasticity has only been reported for glutamatergic synapses after several days of inactivity in cultured neurons (Murthy et al. 2001 ).
Summary
Released DA diffuses beyond the synaptic cleft and concentrations sufficient for receptor activation are reached even several microns from the release site, as termination of the DA signal by the DAT occurs at extrasynaptic sites. Both changes in the frequency as well as changes in the quantal size of vesicular release are expected to have an impact in this type of 'spill-over' (or social) synapse as saturation of postsynaptic receptors is less likely to occur than in a point-to point (or private) synapse. Hence, dopaminergic transmission is highly regulated presynaptically by auto-and heteroreceptors and DATs. The mutual interaction between receptors and DATs provides a complex regulatory system that shapes the DA signal. The striking behavioral effects of psychostimulants, as well as many of the effects of anti-psychotic drugs, seem to result from their interference with this regulation.
